SCHEMBL23708708

SCHEMBL23708708

Cc1cc(-c2ccccc2)ncc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.57
RAB9A P51151 3/20 0.47
NPC1 O15118 3/20 0.47
PDGFRB P09619 1/20 0.47
KDR P35968 1/20 0.47
FLT3 P36888 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
KMT2A Q03164 1/20 0.46
IDO1 P14902 2/20 0.41
TDO2 P48775 2/20 0.41
ASIC3 Q9UHC3 2/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24526057 0.85 HDAC1 (0.46) LDHARAB9ANPC1PDGFRBFLT3
SCHEMBL14985522 0.83 RAB9A (0.54) LDHARAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL15490820 0.82 LDHA (0.51) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL29507311 0.82 LDHA (0.62) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL2481915 0.82 LDHA (0.62) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL15006255 0.80 POLB (0.54) LDHARAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL16906529 0.79 HDAC1 (0.47) KDM4EALDH1A1IDO1TDO2ALOX5AP
SCHEMBL13140208 0.79 ALOX5AP (0.46) LDHAFLT3ALDH1A1ALOX5APFEN1
SCHEMBL19454849 0.78 LDHA (0.59) LDHARAB9ANPC1PDGFRBKDR
SCHEMBL117744 0.78 LDHA (0.64) LDHARAB9ANPC1PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021154966-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS KAMARI PHARMA LTD. (IL) 2021-08-05 WO disclosed